Harvard researchers found that adherence to a Mediterranean diet was associated with longer telomeres, a biomarker of longevity… In a population based cohort study, researchers examined blood sample data from of 4,676 disease-free women from nested case-control studies within the Nurses’ Health Study who had had telomere length measured and …
Read More »Monthly Archives: December 2014
Time-Restricted Eating May Protect Against Diabetes
Limiting food intake to 9-12 hours per day in mice was effective against high-fat, high-fructose and high-sucrose diets…
Read More »Inconsistent Evidence that Testosterone Increases CV Risk
EMA committee recommends that medication labels be changed to reflect more accurate data….
Read More »Technology Can Improve Outcomes
Automated reminders improve medication adherence and cholesterol control…
Read More »Carbs Associated with Higher Diabetes and Heart Disease Risk Factor
Lowering saturated fat intake did not lower saturated fat blood levels but increasing carbs raised levels of palmitoleic acid, a fatty acid associated with disease…
Read More »Niacin Benefits Kidney Mortality
The proportion of patients experiencing a rapid decline in estimated glomerular filtration rate (eGFR) can be decreased significantly with niacin, as can all-cause mortality… Elani Streja, PhD Chief investigator, University of California, Irvine Medical Center, commented on the study, stated, “Across all models of adjustment, patients who took niacin had …
Read More »Why Are Up to 20% Type 2’s Nonresponsive to Exercise?
A new literature review finds that about one in five people with type 2 diabetes do not respond favorably to exercise… Exercise benefits most, but not all, individuals with type 2 diabetes (T2D). The beneficial effects are well studied, but why some individuals do not respond favorably to exercise training …
Read More »Awareness of Glycemic Status Changes Macronutrient Intake
Although those diagnosed with diabetes consumed more protein and less sugar, all individuals consumed less fiber and more saturated fat than recommended….
Read More »The Efficacy of Saxagliptin in Combination Therapy
Saxagliptin shows improved glycemic control when added to other classes of medications in type 2 diabetes patients… Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by extending the half-life of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). The medication can be used as monotherapy or in combination with …
Read More »Type of Medical Care Received Can Improve Patients’ Diabetes Numeracy
Glycemic control unaffected by improved ability to understand numbers…
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.